Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Radiology|December 23, 2017
Ablative Chemoembolization for Hepatocellular Carcinoma: A Prospective Phase I Case-Control Comparison with Conventional ChemoembolizationSimon Chun Ho Yu, Stephen Lam Chan, Kit Fai Lee, et al.
Diseases (Basel, Switzerland)|December 24, 2025
Clinical Implications of Upregulated <i>RSAD2</i> Gene Expression in Hepatocellular CarcinomaLeung Li, Nelson L S Tang, Stephen L Chan, et al.
Cancer|June 23, 2017
A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinomaStephen L Chan, Winnie Yeo, Frankie Mo, et al.
The Journal of Biological Chemistry|July 30, 2011
Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogrammingHsiang-Po Huang, Pin-Hsun Chen, Chun-Ying Yu, et al.
The American Journal of the Medical Sciences|June 16, 2009
Pattern of thyroid autoimmunity in chinese patients with pernicious anemiaJoyce Chee Wun Chan, Herman Sung Yu Liu, Bonnie Chi Shan Kho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative StudyEdwin P Hui, Brigette B Y Ma, Herbert H F Loong, et al.
BMJ Supportive & Palliative Care|January 31, 2020
NEPA efficacy and tolerability during (neo)adjuvant breast cancer chemotherapy with cyclophosphamide and doxorubicinWinnie Yeo, Thomas Kh Lau, Carol Ch Kwok, et al.
Liver Cancer|September 26, 2022
Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical TrialStephen Lam Chan, Chanisa Chotipanich, Su Pin Choo, et al.
British Journal of Cancer|March 21, 2018
Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinomaBrigette Ma, Edwin P Hui, Ann King, et al.
Investigational New Drugs|April 15, 2021
A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinomaStephen L Chan, Paul N M Cheng, Angela M Liu, et al.
Pageof 6